Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Axogen Inc (AXGN)
Axogen Inc (AXGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Axogen Inc 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 USA

www.axogeninc.com P: 386-462-6800 F: 386-462-6801

Description:

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.

Key Statistics

Overview:

Market Capitalization, $K 323,260
Enterprise Value, $K 347,430
Shares Outstanding, K 43,044
Annual Sales, $ 138,580 K
Annual Net Income, $ -28,950 K
Last Quarter Sales, $ 41,270 K
Last Quarter Net Income, $ -4,090 K
EBIT, $ -23,880 K
EBITDA, $ -18,140 K
60-Month Beta 1.12
% of Insider Shareholders 7.21%
% of Institutional Shareholders 83.77%
Float, K 39,941
% Float 92.79%
Short Volume Ratio 0.31

Growth:

1-Year Return -30.07%
3-Year Return -53.64%
5-Year Return -73.74%
5-Year Revenue Growth 129.32%
5-Year Earnings Growth -116.13%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.01 on 11/07/23
Next Earnings Date N/A
Earnings Per Share ttm -0.56
EPS Growth vs. Prev Qtr 37.50%
EPS Growth vs. Prev Year -900.00%
Annual Dividend Yield 0.00%
Most Recent Dividend 1.000 on 01/27/10
Dividend Payable Date 02/12/10
Dividend Payout Ratio 0.00%

AXGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -23.44%
Return-on-Assets % -11.96%
Profit Margin % -20.89%
Net Margin % N/A
Debt/Equity 0.47
Price/Sales 2.30
Price/Cash Flow N/A
Price/Book 3.05
Book Value/Share 2.28
Interest Coverage -45.69

AXGN Dividends

Date Value
01/27/10 $1.0000
02/23/05 $0.0600
07/10/92 $0.0460
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar